
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies
Anna Wolska, Piotr Smolewski
Cancers (2022) Vol. 14, Iss. 15, pp. 3778-3778
Open Access | Times Cited: 15
Anna Wolska, Piotr Smolewski
Cancers (2022) Vol. 14, Iss. 15, pp. 3778-3778
Open Access | Times Cited: 15
Showing 15 citing articles:
Bortezomib in cancer therapy: Mechanisms, side effects, and future proteasome inhibitors
Olusola Sogbein, Pradipta Paul, Meenakshi Umar, et al.
Life Sciences (2024) Vol. 358, pp. 123125-123125
Open Access | Times Cited: 6
Olusola Sogbein, Pradipta Paul, Meenakshi Umar, et al.
Life Sciences (2024) Vol. 358, pp. 123125-123125
Open Access | Times Cited: 6
Advancing brain tumor therapy: unveiling the potential of PROTACs for targeted protein degradation
S.M. Ibrahim, Muhammad Umer Khan, Saadia Noreen, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
S.M. Ibrahim, Muhammad Umer Khan, Saadia Noreen, et al.
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Gold Nanoparticle-Mediated Gene Therapy
Gayathri A. Kanu, Javad B. M. Parambath, Raed O. Abu Odeh, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5366-5366
Open Access | Times Cited: 22
Gayathri A. Kanu, Javad B. M. Parambath, Raed O. Abu Odeh, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5366-5366
Open Access | Times Cited: 22
Integrating Computational Methods and In vitro Experimental Validation Reveals the Pharmacological Mechanism of Selaginella bryopteris (L.) Baker Targeting Major Proteins in Breast Cancer
Amir Mahgoub Awadelkareem, Mitesh Patel, Humera Banu, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38801-e38801
Open Access | Times Cited: 2
Amir Mahgoub Awadelkareem, Mitesh Patel, Humera Banu, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38801-e38801
Open Access | Times Cited: 2
Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets
K Mayuri, Sarojini Sreeraman, Chaitanya Sree Somala, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 867-883
Closed Access | Times Cited: 7
K Mayuri, Sarojini Sreeraman, Chaitanya Sree Somala, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 10, pp. 867-883
Closed Access | Times Cited: 7
Design and optimization strategies of PROTACs and its Application, Comparisons to other targeted protein degradation for multiple oncology therapies
M. Malarvannan, S. Unnikrishnan, S. Monohar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107984-107984
Closed Access | Times Cited: 1
M. Malarvannan, S. Unnikrishnan, S. Monohar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107984-107984
Closed Access | Times Cited: 1
PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
André T. S. Vicente, Jorge A. R. Salvador
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
André T. S. Vicente, Jorge A. R. Salvador
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
BioTech (2023) Vol. 12, Iss. 3, pp. 57-57
Open Access | Times Cited: 3
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
BioTech (2023) Vol. 12, Iss. 3, pp. 57-57
Open Access | Times Cited: 3
Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
(2023)
Open Access | Times Cited: 2
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
(2023)
Open Access | Times Cited: 2
Phosphotriesterase-related protein as a novel prognostic predictor for hepatocellular carcinoma patients
Xiaofan Feng, Yanan Zhou, Shujie Pang, et al.
Chinese Clinical Oncology (2023) Vol. 12, Iss. 4, pp. 37-37
Open Access | Times Cited: 2
Xiaofan Feng, Yanan Zhou, Shujie Pang, et al.
Chinese Clinical Oncology (2023) Vol. 12, Iss. 4, pp. 37-37
Open Access | Times Cited: 2
Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia – a patent review
André T. S. Vicente, Jorge A. R. Salvador
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 6, pp. 397-420
Closed Access | Times Cited: 2
André T. S. Vicente, Jorge A. R. Salvador
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 6, pp. 397-420
Closed Access | Times Cited: 2
Single‐cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition
X. Wang, Feng Yu, Fangfang Wang, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 7
Closed Access
X. Wang, Feng Yu, Fangfang Wang, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 7
Closed Access
H2O2mediated MAPK-mTOR crosstalk determines the XIAP and FLIP degradation pathways and development of resistance to Imatinib
Rajdeep Roy, Tamalika Paul, Samraj Sinha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Rajdeep Roy, Tamalika Paul, Samraj Sinha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Editorial: Protein homeostasis in growth, development and disease
Silvia Masciarelli, Francesco Fazi, Linda M. Hendershot
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access
Silvia Masciarelli, Francesco Fazi, Linda M. Hendershot
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access
Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment
Enrico Milan, Annamaria Gullà
Frontiers in Oncology (2023) Vol. 13
Open Access
Enrico Milan, Annamaria Gullà
Frontiers in Oncology (2023) Vol. 13
Open Access